Global Roundtable EBIT/Assets
The Operating Income to Assets Ratio (EBIT/Assets) of Global Roundtable (GRCU) as of Aug 5, 2026 is 2.42 %.
Get this data via API
Financial Data API
EBIT/Assets
2.42 %
Last updated:
Operating Income to Assets Ratio (EBIT/Assets) of Global Roundtable is 2026 2.42 % . Operating Income to Assets Ratio (EBIT/Assets) of Global Roundtable was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Global Roundtable Stock analysis
What does Global Roundtable do? Green Cures & Botanical Distribution Inc. was founded in 2014 in California, USA. The company is a provider of natural products, particularly CBD products. The main business of Green Cures & Botanical Distribution Inc. is the manufacturing and sale of CBD products. CBD, a natural component of hemp, is known for its health benefits and does not have the psychoactive effects of THC. The company offers a wide range of CBD products, including oils, capsules, tinctures, extracts, salves, balms, and more, in various strengths to meet the individual needs of customers. In addition, the company also offers other natural products such as hemp products and supplements. Green Cures & Botanical Distribution Inc. aims to produce high-quality natural products that support the well-being and health of customers. The company's business model includes participation in the hemp industry to foster growth and gain a competitive advantage. Green Cures & Botanical Distribution Inc. is divided into different sectors to cover various aspects of the business, including the production and sale of CBD products, offering hemp products, and focusing on supplements and natural products. Research and development are core competencies of the company, which strives to explore and develop innovative natural products that have the potential to improve customers' well-being and health. Green Cures & Botanical Distribution Inc. places a strong emphasis on quality and sustainability, using only natural ingredients sourced from organic farming and avoiding synthetic chemicals and pesticides. The company is also committed to environmental protection and social responsibility. Overall, Green Cures & Botanical Distribution Inc. is a leading provider of natural products, particularly CBD products, offering a wide range of options. Research and development, as well as quality and sustainability, are central to the company's business model. Global Roundtable is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Global Roundtable stock
Operating Income to Assets Ratio (EBIT/Assets) of Global Roundtable is 2.42 % in 2026.
On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Global Roundtable since 2006 – with annual values, charts, and detailed analysis.
EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Global Roundtable with sector peers and the industry average to assess whether it is attractive.
To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).
Access this data via the Eulerpool API
Profitability — Global Roundtable
ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets
All Key Metrics — Global Roundtable
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth